Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...

GlobalData’s director of therapy research & analysis in medical devices says the new entity could make an attractive ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), Technology (Hematology), Application (Genetic Testing, Autoimmune Disease), Test Type ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...

DUBAI, UAE, Feb. 3, 2025 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with global ...

Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...

Early diagnosis through the use of in vitro diagnostics (IVDs) plays a critical role in patient outcomes and in supporting the healthcare system as a whole. IVDs are defined in the new EU IVDR ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...